GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the inhibitor NXL104 covalent adduct with tb B- lactamase

Analyse Crystal structure of the inhibitor NXL104 covalent adduct with tb B- lactamase in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4DF6
Type
protein
Length
265 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase
EC
3.5.2.6
UniProt
P0C5C1
Ligands
NXL, PO4
Pockets
1 · best druggability 0.38

Structure

x-ray diffraction · 1 distinct chain · 45% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactamase (EC 3.5.2.6)protein26545% helix, 16% strandP0C5C1

Ligands and binding sites

  • NXL · (2S,5R)-1-formyl-5-[(sulfooxy)amino]piperidine-2-carboxamide · ligand · chains A
  • PO4 · Phosphate ion · ion · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11080.380.7520PO4, NXL

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 4DF6 · Crystal Structure of the inhibitor NXL104 Covalent Adduct with TB B-lactamase · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.